ANTERIS TECHNOLOGIES LIMITED (AVR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

AVR - ANTERIS TECHNOLOGIES LIMITED

FNArena Sector : NONE

Year End: December

GICS Industry Group : Consumer Durables & Apparel

Debt/EBITDA: N/A

Index: ALL-ORDS

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$4.58 21 Apr 2025	0.000 OPEN $4.58	0.000 HIGH $4.58	0 LOW $4.58

TARGET

$15.00

227.5% upside

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	N/A	- 247.7	xxx
DPS (cps)	xxx	N/A	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
PE Ratio	xxx	N/A	N/A	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2018	2019	2020	2021	2022	2023
EPS Basic	xxx	xxx	xxx	xxx	xxx	-431.5
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	4.1 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	160.5
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	-51.4 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-1,637.85 %

EPS Basic

Negative
Growth
Slowing

DPS All

Negative
Growth
Slowing

Sales/Revenue

Negative
Growth
Slowing

Book Value Per Share

Negative
Growth
Slowing

Net Operating Cash Flow

Negative
Growth
Slowing

Net Profit Margin

Negative
Growth
Slowing

Title	2018	2019	2020	2021	2022	2023
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	-322.02 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	-307.29 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	-194.66 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-322.02 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	-314.24 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	-55.0 M

Return on Capital Employed

Negative
Growth
Slowing

Return on Invested Capital

Negative
Growth
Slowing

Return on Assets

Negative
Growth
Slowing

Return on Equity

Negative
Growth
Slowing

Return on Total Capital

Negative
Growth
Slowing

Free Cash Flow ex dividends

Negative
Growth
Slowing

Title	2018	2019	2020	2021	2022	2023
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Total Debt	xxx	xxx	xxx	xxx	xxx	2 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	-
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	31 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	11.93

Short-Term Debt

Negative
Growth
Slowing

Long Term Debt

Negative
Growth
Slowing

Total Debt

Negative
Growth
Slowing

Goodwill - Gross

Cash & Equivalents - Generic

Negative
Growth
Slowing

Price To Book Value

Negative
Growth
Slowing

Title	2018	2019	2020	2021	2022	2023
Capex	xxx	xxx	xxx	xxx	xxx	3.6 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	86.67 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	39 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	36 M
Research & Development	xxx	xxx	xxx	xxx	xxx	24 M
Investments - Total	xxx	xxx	xxx	xxx	xxx	0 M

Capex

Negative
Growth
Slowing

Capex % of Sales

Negative
Growth
Slowing

Cost of Goods Sold

Negative
Growth
Slowing

Selling, General & Admin. Exp & Other

Negative
Growth
Slowing

Research & Development

Negative
Growth
Slowing

Investments - Total

Negative
Growth
Slowing

Negative

Growth

Slowing

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Bell Potter	25/03/2025	1	Speculative Buy	$15.00	227.51%	Bell Potter notes Anteris Technologies has announced its one-year safety and efficacy data for aortic stenosis patients treated with DurAVR. The broker views the data as indicative of future outcomes from an approval study for DurAVR, which has the potential to compete with the Sapien valve that continues to dominate the US market with an estimated 65–70% market share. Bell Potter believes the data have vindicated "superior" patient outcomes compared to Sapien, subject to further studies. No change to Speculative Buy rating and $15 target price. FORECAST Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -247.70 cents. Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -212.70 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Bell Potter

25/03/2025

Speculative Buy

$15.00

227.51%

Bell Potter notes Anteris Technologies has announced its one-year safety and efficacy data for aortic stenosis patients treated with DurAVR.

The broker views the data as indicative of future outcomes from an approval study for DurAVR, which has the potential to compete with the Sapien valve that continues to dominate the US market with an estimated 65–70% market share.

Bell Potter believes the data have vindicated "superior" patient outcomes compared to Sapien, subject to further studies.

No change to Speculative Buy rating and $15 target price.

FORECAST
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -247.70 cents.
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of minus -212.70 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
No data available in table

Access Extra Coverage Research History >

AVR STOCK CHART

FNArena News on AVR

Next Week At A Glance – 29 Jul-2 Aug 2024

Jul 26 2024 - Weekly Reports

Dividend Yield Today On Last Actual Payout :	N/A
Estimated Dividend Growth (Average Of Past Three Years)
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

ANTERIS TECHNOLOGIES LIMITED (AVR)
Share Price Analysis and Chart